XNK Therapeutics announces poster presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Posted on by

HUDDINGE, Sweden, Nov. 6, 2023 /PRNewswire/ — XNK Therapeutics AB (“XNK”) participates in the SITC meeting, which takes place in San Diego, USA, and will present the latest research relating to the company’s leading natural killer (NK) cell therapies. Two abstracts have been accepted for…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.